Global Systemic Anti-Infectives Market Growth (Status and Outlook) 2023-2029
Anti-infective drugs are drugs that have the effect of killing or inhibiting the above pathogenic microorganisms and are applied systemically or topically by oral, intramuscular, intravenous or topical application. Systemic anti-infective drugs are the basic drugs and are widely used in the treatment of bacterial, fungal, chlamydial and viral infections and other infectious complications arising from other diseases.
LPI (LP Information)' newest research report, the “Systemic Anti-Infectives Industry Forecast” looks at past sales and reviews total world Systemic Anti-Infectives sales in 2022, providing a comprehensive analysis by region and market sector of projected Systemic Anti-Infectives sales for 2023 through 2029. With Systemic Anti-Infectives sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Systemic Anti-Infectives industry.
This Insight Report provides a comprehensive analysis of the global Systemic Anti-Infectives landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Systemic Anti-Infectives portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Systemic Anti-Infectives market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Systemic Anti-Infectives and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Systemic Anti-Infectives.
The global Systemic Anti-Infectives market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Systemic Anti-Infectives is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Systemic Anti-Infectives is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Systemic Anti-Infectives is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Systemic Anti-Infectives players cover Pfizer, Sumitomo Dainippon Pharma, MSD, Bayer, Bristol-Myers Squibb, Dechra, Alandalous, Chiatai Tianqing and Hailing Pharm, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Systemic Anti-Infectives market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Injections
Tablets
Capsules & Pellets
Others
Segmentation by application
Hospital
Clinic
Drugstores
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Pfizer
Sumitomo Dainippon Pharma
MSD
Bayer
Bristol-Myers Squibb
Dechra
Alandalous
Chiatai Tianqing
Hailing Pharm
Southwest Pharmaceutical Co., Ltd.
Guangzhou Baiyunshan
Harbin Pharmaceutical Group
CSPC Pharmaceutical
North China Pharmaceutical
Sinopharm
Luoxin Pharmaceutical
CR Pharma
Duopharma Biotech Group
PT Infion Pharma
Bright-gene
Please note: The report will take approximately 2 business days to prepare and deliver.
- *This is a tentative TOC and the final deliverable is subject to change.*
- 1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Years Considered
- 1.3 Research Objectives
- 1.4 Market Research Methodology
- 1.5 Research Process and Data Source
- 1.6 Economic Indicators
- 1.7 Currency Considered
- 1.8 Market Estimation Caveats
- 2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Systemic Anti-Infectives Market Size 2018-2029
- 2.1.2 Systemic Anti-Infectives Market Size CAGR by Region 2018 VS 2022 VS 2029
- 2.2 Systemic Anti-Infectives Segment by Type
- 2.2.1 Injections
- 2.2.2 Tablets
- 2.2.3 Capsules & Pellets
- 2.2.4 Others
- 2.3 Systemic Anti-Infectives Market Size by Type
- 2.3.1 Systemic Anti-Infectives Market Size CAGR by Type (2018 VS 2022 VS 2029)
- 2.3.2 Global Systemic Anti-Infectives Market Size Market Share by Type (2018-2023)
- 2.4 Systemic Anti-Infectives Segment by Application
- 2.4.1 Hospital
- 2.4.2 Clinic
- 2.4.3 Drugstores
- 2.4.4 Others
- 2.5 Systemic Anti-Infectives Market Size by Application
- 2.5.1 Systemic Anti-Infectives Market Size CAGR by Application (2018 VS 2022 VS 2029)
- 2.5.2 Global Systemic Anti-Infectives Market Size Market Share by Application (2018-2023)
- 3 Systemic Anti-Infectives Market Size by Player
- 3.1 Systemic Anti-Infectives Market Size Market Share by Players
- 3.1.1 Global Systemic Anti-Infectives Revenue by Players (2018-2023)
- 3.1.2 Global Systemic Anti-Infectives Revenue Market Share by Players (2018-2023)
- 3.2 Global Systemic Anti-Infectives Key Players Head office and Products Offered
- 3.3 Market Concentration Rate Analysis
- 3.3.1 Competition Landscape Analysis
- 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
- 3.4 New Products and Potential Entrants
- 3.5 Mergers & Acquisitions, Expansion
- 4 Systemic Anti-Infectives by Regions
- 4.1 Systemic Anti-Infectives Market Size by Regions (2018-2023)
- 4.2 Americas Systemic Anti-Infectives Market Size Growth (2018-2023)
- 4.3 APAC Systemic Anti-Infectives Market Size Growth (2018-2023)
- 4.4 Europe Systemic Anti-Infectives Market Size Growth (2018-2023)
- 4.5 Middle East & Africa Systemic Anti-Infectives Market Size Growth (2018-2023)
- 5 Americas
- 5.1 Americas Systemic Anti-Infectives Market Size by Country (2018-2023)
- 5.2 Americas Systemic Anti-Infectives Market Size by Type (2018-2023)
- 5.3 Americas Systemic Anti-Infectives Market Size by Application (2018-2023)
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Brazil
- 6 APAC
- 6.1 APAC Systemic Anti-Infectives Market Size by Region (2018-2023)
- 6.2 APAC Systemic Anti-Infectives Market Size by Type (2018-2023)
- 6.3 APAC Systemic Anti-Infectives Market Size by Application (2018-2023)
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
- 7 Europe
- 7.1 Europe Systemic Anti-Infectives by Country (2018-2023)
- 7.2 Europe Systemic Anti-Infectives Market Size by Type (2018-2023)
- 7.3 Europe Systemic Anti-Infectives Market Size by Application (2018-2023)
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
- 8 Middle East & Africa
- 8.1 Middle East & Africa Systemic Anti-Infectives by Region (2018-2023)
- 8.2 Middle East & Africa Systemic Anti-Infectives Market Size by Type (2018-2023)
- 8.3 Middle East & Africa Systemic Anti-Infectives Market Size by Application (2018-2023)
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
- 9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers & Growth Opportunities
- 9.2 Market Challenges & Risks
- 9.3 Industry Trends
- 10 Global Systemic Anti-Infectives Market Forecast
- 10.1 Global Systemic Anti-Infectives Forecast by Regions (2024-2029)
- 10.1.1 Global Systemic Anti-Infectives Forecast by Regions (2024-2029)
- 10.1.2 Americas Systemic Anti-Infectives Forecast
- 10.1.3 APAC Systemic Anti-Infectives Forecast
- 10.1.4 Europe Systemic Anti-Infectives Forecast
- 10.1.5 Middle East & Africa Systemic Anti-Infectives Forecast
- 10.2 Americas Systemic Anti-Infectives Forecast by Country (2024-2029)
- 10.2.1 United States Systemic Anti-Infectives Market Forecast
- 10.2.2 Canada Systemic Anti-Infectives Market Forecast
- 10.2.3 Mexico Systemic Anti-Infectives Market Forecast
- 10.2.4 Brazil Systemic Anti-Infectives Market Forecast
- 10.3 APAC Systemic Anti-Infectives Forecast by Region (2024-2029)
- 10.3.1 China Systemic Anti-Infectives Market Forecast
- 10.3.2 Japan Systemic Anti-Infectives Market Forecast
- 10.3.3 Korea Systemic Anti-Infectives Market Forecast
- 10.3.4 Southeast Asia Systemic Anti-Infectives Market Forecast
- 10.3.5 India Systemic Anti-Infectives Market Forecast
- 10.3.6 Australia Systemic Anti-Infectives Market Forecast
- 10.4 Europe Systemic Anti-Infectives Forecast by Country (2024-2029)
- 10.4.1 Germany Systemic Anti-Infectives Market Forecast
- 10.4.2 France Systemic Anti-Infectives Market Forecast
- 10.4.3 UK Systemic Anti-Infectives Market Forecast
- 10.4.4 Italy Systemic Anti-Infectives Market Forecast
- 10.4.5 Russia Systemic Anti-Infectives Market Forecast
- 10.5 Middle East & Africa Systemic Anti-Infectives Forecast by Region (2024-2029)
- 10.5.1 Egypt Systemic Anti-Infectives Market Forecast
- 10.5.2 South Africa Systemic Anti-Infectives Market Forecast
- 10.5.3 Israel Systemic Anti-Infectives Market Forecast
- 10.5.4 Turkey Systemic Anti-Infectives Market Forecast
- 10.5.5 GCC Countries Systemic Anti-Infectives Market Forecast
- 10.6 Global Systemic Anti-Infectives Forecast by Type (2024-2029)
- 10.7 Global Systemic Anti-Infectives Forecast by Application (2024-2029)
- 11 Key Players Analysis
- 11.1 Pfizer
- 11.1.1 Pfizer Company Information
- 11.1.2 Pfizer Systemic Anti-Infectives Product Offered
- 11.1.3 Pfizer Systemic Anti-Infectives Revenue, Gross Margin and Market Share (2018-2023)
- 11.1.4 Pfizer Main Business Overview
- 11.1.5 Pfizer Latest Developments
- 11.2 Sumitomo Dainippon Pharma
- 11.2.1 Sumitomo Dainippon Pharma Company Information
- 11.2.2 Sumitomo Dainippon Pharma Systemic Anti-Infectives Product Offered
- 11.2.3 Sumitomo Dainippon Pharma Systemic Anti-Infectives Revenue, Gross Margin and Market Share (2018-2023)
- 11.2.4 Sumitomo Dainippon Pharma Main Business Overview
- 11.2.5 Sumitomo Dainippon Pharma Latest Developments
- 11.3 MSD
- 11.3.1 MSD Company Information
- 11.3.2 MSD Systemic Anti-Infectives Product Offered
- 11.3.3 MSD Systemic Anti-Infectives Revenue, Gross Margin and Market Share (2018-2023)
- 11.3.4 MSD Main Business Overview
- 11.3.5 MSD Latest Developments
- 11.4 Bayer
- 11.4.1 Bayer Company Information
- 11.4.2 Bayer Systemic Anti-Infectives Product Offered
- 11.4.3 Bayer Systemic Anti-Infectives Revenue, Gross Margin and Market Share (2018-2023)
- 11.4.4 Bayer Main Business Overview
- 11.4.5 Bayer Latest Developments
- 11.5 Bristol-Myers Squibb
- 11.5.1 Bristol-Myers Squibb Company Information
- 11.5.2 Bristol-Myers Squibb Systemic Anti-Infectives Product Offered
- 11.5.3 Bristol-Myers Squibb Systemic Anti-Infectives Revenue, Gross Margin and Market Share (2018-2023)
- 11.5.4 Bristol-Myers Squibb Main Business Overview
- 11.5.5 Bristol-Myers Squibb Latest Developments
- 11.6 Dechra
- 11.6.1 Dechra Company Information
- 11.6.2 Dechra Systemic Anti-Infectives Product Offered
- 11.6.3 Dechra Systemic Anti-Infectives Revenue, Gross Margin and Market Share (2018-2023)
- 11.6.4 Dechra Main Business Overview
- 11.6.5 Dechra Latest Developments
- 11.7 Alandalous
- 11.7.1 Alandalous Company Information
- 11.7.2 Alandalous Systemic Anti-Infectives Product Offered
- 11.7.3 Alandalous Systemic Anti-Infectives Revenue, Gross Margin and Market Share (2018-2023)
- 11.7.4 Alandalous Main Business Overview
- 11.7.5 Alandalous Latest Developments
- 11.8 Chiatai Tianqing
- 11.8.1 Chiatai Tianqing Company Information
- 11.8.2 Chiatai Tianqing Systemic Anti-Infectives Product Offered
- 11.8.3 Chiatai Tianqing Systemic Anti-Infectives Revenue, Gross Margin and Market Share (2018-2023)
- 11.8.4 Chiatai Tianqing Main Business Overview
- 11.8.5 Chiatai Tianqing Latest Developments
- 11.9 Hailing Pharm
- 11.9.1 Hailing Pharm Company Information
- 11.9.2 Hailing Pharm Systemic Anti-Infectives Product Offered
- 11.9.3 Hailing Pharm Systemic Anti-Infectives Revenue, Gross Margin and Market Share (2018-2023)
- 11.9.4 Hailing Pharm Main Business Overview
- 11.9.5 Hailing Pharm Latest Developments
- 11.10 Southwest Pharmaceutical Co., Ltd.
- 11.10.1 Southwest Pharmaceutical Co., Ltd. Company Information
- 11.10.2 Southwest Pharmaceutical Co., Ltd. Systemic Anti-Infectives Product Offered
- 11.10.3 Southwest Pharmaceutical Co., Ltd. Systemic Anti-Infectives Revenue, Gross Margin and Market Share (2018-2023)
- 11.10.4 Southwest Pharmaceutical Co., Ltd. Main Business Overview
- 11.10.5 Southwest Pharmaceutical Co., Ltd. Latest Developments
- 11.11 Guangzhou Baiyunshan
- 11.11.1 Guangzhou Baiyunshan Company Information
- 11.11.2 Guangzhou Baiyunshan Systemic Anti-Infectives Product Offered
- 11.11.3 Guangzhou Baiyunshan Systemic Anti-Infectives Revenue, Gross Margin and Market Share (2018-2023)
- 11.11.4 Guangzhou Baiyunshan Main Business Overview
- 11.11.5 Guangzhou Baiyunshan Latest Developments
- 11.12 Harbin Pharmaceutical Group
- 11.12.1 Harbin Pharmaceutical Group Company Information
- 11.12.2 Harbin Pharmaceutical Group Systemic Anti-Infectives Product Offered
- 11.12.3 Harbin Pharmaceutical Group Systemic Anti-Infectives Revenue, Gross Margin and Market Share (2018-2023)
- 11.12.4 Harbin Pharmaceutical Group Main Business Overview
- 11.12.5 Harbin Pharmaceutical Group Latest Developments
- 11.13 CSPC Pharmaceutical
- 11.13.1 CSPC Pharmaceutical Company Information
- 11.13.2 CSPC Pharmaceutical Systemic Anti-Infectives Product Offered
- 11.13.3 CSPC Pharmaceutical Systemic Anti-Infectives Revenue, Gross Margin and Market Share (2018-2023)
- 11.13.4 CSPC Pharmaceutical Main Business Overview
- 11.13.5 CSPC Pharmaceutical Latest Developments
- 11.14 North China Pharmaceutical
- 11.14.1 North China Pharmaceutical Company Information
- 11.14.2 North China Pharmaceutical Systemic Anti-Infectives Product Offered
- 11.14.3 North China Pharmaceutical Systemic Anti-Infectives Revenue, Gross Margin and Market Share (2018-2023)
- 11.14.4 North China Pharmaceutical Main Business Overview
- 11.14.5 North China Pharmaceutical Latest Developments
- 11.15 Sinopharm
- 11.15.1 Sinopharm Company Information
- 11.15.2 Sinopharm Systemic Anti-Infectives Product Offered
- 11.15.3 Sinopharm Systemic Anti-Infectives Revenue, Gross Margin and Market Share (2018-2023)
- 11.15.4 Sinopharm Main Business Overview
- 11.15.5 Sinopharm Latest Developments
- 11.16 Luoxin Pharmaceutical
- 11.16.1 Luoxin Pharmaceutical Company Information
- 11.16.2 Luoxin Pharmaceutical Systemic Anti-Infectives Product Offered
- 11.16.3 Luoxin Pharmaceutical Systemic Anti-Infectives Revenue, Gross Margin and Market Share (2018-2023)
- 11.16.4 Luoxin Pharmaceutical Main Business Overview
- 11.16.5 Luoxin Pharmaceutical Latest Developments
- 11.17 CR Pharma
- 11.17.1 CR Pharma Company Information
- 11.17.2 CR Pharma Systemic Anti-Infectives Product Offered
- 11.17.3 CR Pharma Systemic Anti-Infectives Revenue, Gross Margin and Market Share (2018-2023)
- 11.17.4 CR Pharma Main Business Overview
- 11.17.5 CR Pharma Latest Developments
- 11.18 Duopharma Biotech Group
- 11.18.1 Duopharma Biotech Group Company Information
- 11.18.2 Duopharma Biotech Group Systemic Anti-Infectives Product Offered
- 11.18.3 Duopharma Biotech Group Systemic Anti-Infectives Revenue, Gross Margin and Market Share (2018-2023)
- 11.18.4 Duopharma Biotech Group Main Business Overview
- 11.18.5 Duopharma Biotech Group Latest Developments
- 11.19 PT Infion Pharma
- 11.19.1 PT Infion Pharma Company Information
- 11.19.2 PT Infion Pharma Systemic Anti-Infectives Product Offered
- 11.19.3 PT Infion Pharma Systemic Anti-Infectives Revenue, Gross Margin and Market Share (2018-2023)
- 11.19.4 PT Infion Pharma Main Business Overview
- 11.19.5 PT Infion Pharma Latest Developments
- 11.20 Bright-gene
- 11.20.1 Bright-gene Company Information
- 11.20.2 Bright-gene Systemic Anti-Infectives Product Offered
- 11.20.3 Bright-gene Systemic Anti-Infectives Revenue, Gross Margin and Market Share (2018-2023)
- 11.20.4 Bright-gene Main Business Overview
- 11.20.5 Bright-gene Latest Developments
- 12 Research Findings and Conclusion
Research Assistance
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook